This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

Scientists discover first-ever mineral-based treatment for widespread disease using the structure of crystals

NHM scientists discover first-ever mineral-based treatment for widespread disease using the structure of crystals
An illustration of part of a 3MR showing how the double lever mechanisms works in CZS-(Na,H). Credit: Jason Lively, Aaron J. Celestian

In a groundbreaking discovery, scientists at the Natural History Museum of Los Angeles County and pharmaceutical firm AstraZeneca have published the first-ever mineral-based treatment for a widespread disease.

Reported in the journal PLOS One, the study by mineralogist Dr. Aaron Celestian, Curator of Mineral Sciences at NHM, and pharmaceutical chemist Dr. Jason Lively, opens the door to more advanced mineral-based treatments in the future.

The paper describes how have been used as a new treatment for hyperkalemia, a disease that affects roughly 350 million people across the planet. Hyperkalemia strikes when a person has too much in their blood and cannot regulate potassium levels. It can result in in acute cases or cause kidney and liver dysfunction or failure in persistent cases that last decades.

"For people suffering from hyperkalemia, the biological processes that regulate potassium in the body are not working optimally, so they have to constantly manage their condition through medications that have potentially harmful side effects and dietary restrictions," says Celestian.

The new treatment lets patients flush the excess potassium through ion transfer. "The crystals find the potassium, absorb it, and then excess gets filtered out of the body through the kidneys," says Celestian.

The researchers used the crystal structure of cubic zirconium silicate to develop a treatment without harmful biological interaction—and associated negative side effects. This is a new way to alleviate on patients that other treatments have.

  • NHM scientists discover first-ever mineral-based treatment for widespread disease using the structure of crystals
    Cubic zirconium crystal structures examined under the Scanning Electron Microscope. Credit: Aaron Celestian
  • NHM scientists discover first-ever mineral-based treatment for widespread disease using the structure of crystals
    Aaron Celestian (right) analyzing crystals on the scanning electron microscope. Credit: Aaron Celestian

"It's like material engineering using minerals as a template," says Celestian. "Nature's already grown incredible tools for treating illnesses, and we're only just beginning to harness those tools."

Besides having significantly less biological interaction, mineral-based therapies might offer the chance for more durable treatments. Using the structure of crystals means that similar treatments could potentially overcome mutations that make things like viruses so difficult to treat effectively.

"Minerals probably don't care about how a virus mutates, as long as it has those building block proteins that the mineral likes to interact with," says Celestian.

More information: Jason Lively et al, In situ potassium and hydrogen ion exchange into a cubic zirconium silicate microporous material, PLOS ONE (2024). DOI: 10.1371/journal.pone.0298661

Journal information: PLoS ONE
Citation: Scientists discover first-ever mineral-based treatment for widespread disease using the structure of crystals (2024, March 27) retrieved 20 May 2024 from https://medicalxpress.com/news/2024-03-scientists-mineral-based-treatment-widespread.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New mathematical model shows how the body regulates potassium

126 shares

Feedback to editors